
Maite Bourlon
@bourlonmaite
Oncology | Urologic Oncology @incmnszmx IDEA Award | Global Oncology TF @ASCO| Fellow @JCOGO_ASCO @oncofertilty LATAM @UPMex WWCC Award @ConquerCancerFd
ID: 1020128956475817985
20-07-2018 02:11:11
774 Tweet
2,2K Takipçi
1,1K Takip Edilen

Just at #gu2024 ASCO 🔹Keynote 564! Adjuvant pembrolizumab in resected high risk RCC has OS benefit! Toni Choueiri, MD 🔸Pedro C Barata, MD MSc FACP discussed the data & highlighted our ASCO Daily News of What to do in patients recurring after adjuvant pembrolizumab? dailynews.ascopubs.org/do/using-clini…
